Japan’s Takeda Pharmaceutical Company Limited has announced that it will establish a new commercial subsidiary to drive its pharmaceutical pipeline in Brazil.
The new subsidiary represents the 12th new strategic expansion taken on by the company since January 2009 after new offices were opened in Canada, Spain, Portugal, Ireland, Mexico, Sweden, Norway, Denmark, Belgium, Luxembourg and Turkey.
Takeda Pharmaceuticals International executive vice-president (EVP) international operations Alan MacKenzie said that this opportunity would drive Takeda’s ability to maximize the potential of its pipeline in Brazil.
“Brazil is an important country in the Latin American region for Takeda to ensure that we are providing our products where patients need them,” he said.
The Brazilian pharmaceutical market accounts for more than 40% of the pharmaceutical sales throughout Latin America and is forecasted to grow rapidly by as much as 8.5% every year.